Vimarsana
Biggest News Aggregation in the World

Pigmented Glia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pigmented Glia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pigmented Glia Today - Breaking & Trending Today

Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting - Vimarsana News

Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting

Published: March 13, 2024

WATERTOWN, Mass., March 13, 2024 -- Vigil Neuroscience, Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases,...

Source: marketscreener.com
Related Topics:
United StatesDavids LynchMegan McgrathZbigniew WszolekLeah GibsonAbbie RenouxVigil Neuroscience IncInvestor Relations Corporate CommunicationsUniversity College London Institute Of NeurologyAmerican Academy Of NeurologyNational Hospital For Neurology NeurosurgeryAnnual MeetingInterim ResultsFirst Interventional PhaseAdult Onset LeukoencephalopathyAxonal SpheroidsPigmented GliaMayo ClinicFindings FromNatural History StudyNational HospitalUniversity College London InstituteEnhances Microglial SurvivalInvestor Relations
Vigil Neuroscience Reports Second Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

Vigil Neuroscience Reports Second Quarter 2022 Financial Results and Provides Business Update

Published: August 8, 2022

08.08.2022 - – Initiated a Phase 1 trial of VGL101 in healthy volunteers in Australia – – Received U.S. FDA orphan drug designation for VGL101 for the treatment of patients with ALSP – – Prioritizing VGL101 in ALSP and small molecule TREM2 agonist programs; ...

Source: wallstreet-online.de
Related Topics:
United KingdomSuzanne BruhnIvana MagovMegan Mcgrath MacdougallExchange CommissionAgonist ProgramAlzheimer Association International ConferenceEuropean Academy Of NeurologyDrug AdministrationVigil Neuroscience IncChief Executive OfficerMonoclonal AntibodyDrug DesignationEuropean AcademyOnset LeukoencephalopathyAxonal SpheroidsPigmented GliaInitial MisdiagnosisAssociation International ConferenceHuman MicrogliaAdult Onset LeukoencephalopathyPresenting SymptomsClinical CourseInvestigational New DrugVigil Neuroscience